c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Enliven, FDA agree on phase 3 trial design for relcobatinib for chronic myeloid leukemia
Seeking Alpha | Oct 6, 2026 11:12 PM EDT
Read original article